Martine L M Lamfers (Martine Lamfers)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Venues

Cancers

British journal of cancer

Viruses

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Federica Fabro, Trisha V Kers, Kate Jo-Ann Feller, Cecile Beerens, Ioannis Ntafoulis, Ahmed Idbaïh, Maïté Verreault, Kate Connor, Archita Biswas, Manuela Salvucci, Jochen H M Prehn, Annette T Byrne, Alice C O'Farrell, Diether Lambrechts, Gonca Dilcan, Francesca Lodi, Ingrid Arijs, Andreas Kremer, Romain Tching Chi Yen, Miao-Ping Chien, Martine L M Lamfers, Sieger Leenstra
Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells. International journal of molecular sciences 24 (21) (2023)
Ioannis Ntafoulis, Anne Kleijn, Jie Ju, Kevin Jimenez-Cowell, Federica Fabro, Michelle Klein, Romain Tching Chi Yen, Rutger K Balvers, Yunlei Li, Andrew P Stubbs, Trisha V Kers, Johan M Kros, Sean E Lawler, Laurens V Beerepoot, Andreas Kremer, Ahmed Idbaih, Maite Verreault, Anthony L Byrne, Alice C O'Farrell, Kate Connor, Archita Biswas, Manuela Salvucci, Jochen H M Prehn, Diether Lambrechts, Gonca Dilcan, Francesca Lodi, Ingrid Arijs, Martin J Van Den Bent, Clemens M F Dirven, Sieger Leenstra, null null, Martine L M Lamfers
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers. British journal of cancer (2023)
Ioannis Ntafoulis, Stijn L W Koolen, Sieger Leenstra, Martine L M Lamfers
Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for Glioblastoma. Cancers 14 (15) (2022)
Federica Fabro, Martine L M Lamfers, Sieger Leenstra
Advancements, Challenges, and Future Directions in Tackling Glioblastoma Resistance to Small Kinase Inhibitors. Cancers 14 (3) (2022)
Angela Costagliola di Polidoro, Giorgia Zambito, Joost Haeck, Laura Mezzanotte, Martine L M Lamfers, Paolo Antonio Netti, Enza Torino
Theranostic Design of Angiopep-2 Conjugated Hyaluronic Acid Nanoparticles (Thera-ANG-cHANPs) for Dual Targeting and Boosted Imaging of Glioma Cells. Cancers 13 (3) (2021)
Viktorija Juric, Heiko Düssmann, Martine L M Lamfers, Jochen H M Prehn, Markus Rehm, Brona M Murphy
Transcriptional CDK Inhibitors CYC065 and THZ1 Induce Apoptosis in Glioma Stem Cells Derived from Recurrent GBM. Cells 10 (5) (2021)
Eftychia Stavrakaki, Clemens M F Dirven, Martine L M Lamfers
Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response. Cancers 13 (4) (2021)
Laura Hofman, Sean E Lawler, Martine L M Lamfers
The Multifaceted Role of Macrophages in Oncolytic Virotherapy. Viruses 13 (8) (2021)
Cassandra Verheul, Ioannis Ntafoulis, Trisha V Kers, Youri Hoogstrate, Pier G Mastroberardino, Sander Barnhoorn, César Payán-Gómez, Romain Tching Chi Yen, Eduard A Struys, Stijn L W Koolen, Clemens M F Dirven, Sieger Leenstra, Pim J French, Martine L M Lamfers
Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell cultures. Neuro-oncology advances 3 (1) (2021)
Wouter B L van den Bossche, Arnaud J P E Vincent, Cristina Teodosio, Jeroen Koets, Aladdin Taha, Anne Kleijn, Sandra de Bruin, Willem A Dik, Daniela Damasceno, Julia Almeida, Diederik W J Dippel, Clemens M F Dirven, Alberto Orfao, Martine L M Lamfers, Jacques J M van Dongen, null null
Monocytes carrying GFAP detect glioma, brain metastasis and ischaemic stroke, and predict glioblastoma survival. Brain communications 3 (1) (2020)

Martine L M Lamfers.css-eqlu8i{font-size:small;padding-left:4px;} (Martine Lamfers)

Publication Activity (10 Years)

Top Topics

Top Venues

Martine L M Lamfers (Martine Lamfers)